Views & Analysis If Virtual Reality is really therapeutic, pharma beware! How far can the potential of Virtual Reality extend and which healthcare stakeholders will take the lead?
Views & Analysis AI is the future - but is that future now? The latest ‘big tech’ wave is getting many in the healthcare industry excited.
Views & Analysis Digital Health Round-up - Trump's reign begins A round-up of this week's digital healthcare news. Marco Ricci reports.
News Pharma joins digital health debate at CES Novartis, J&J, Verily and Philips will all feature at this year’s Digital Health Summit.
News Diabetes wearable and VR platform winners at Healthtech Summ... Insulin delivery wearable and neuro-rehabilitation virtual reality scoop top awards.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
